Microgravity can take a toll on the human body, causing cardiovascular changes like irregular heartbeats in astronauts. However, understanding how extended space missions impact the heart at a molecular level has been challenging. “It’s not possible to do the different molecular and functional studies in human astronauts,” explains study co-author Deok-Ho Kim, a biomedical engineer at Johns Hopkins University.
To tackle this challenge, Kim and his team engineered heart tissue and sent it to the
While in space, sensors monitored the tissue’s strength and beating patterns in real time, and the results were striking. After just 12 days on the ISS, the heart tissue's contraction strength had nearly halved, while the samples that remained on Earth stayed relatively stable. The tissues’ beats also became increasingly irregular, with the time between each beat stretching over five times by day 19. Interestingly, these irregularities resolved after the tissue returned to Earth, suggesting that astronauts, like
Further analysis revealed that spaceflight caused significant structural changes in the heart tissue. Protein bundles responsible for muscle contractions, called sarcomeres, became shorter and more disordered. The mitochondria, cells' energy producers, also appeared swollen and fragmented. Additionally, genes linked to inflammation and heart disorders were more active in the tissues from space, while those crucial for heart contraction and energy production had reduced expression.
While this heart-on-a-chip model doesn’t capture all cardiovascular changes, it offers a valuable tool for studying the effects of microgravity on the human body. Joseph Wu, a cardiologist at Stanford University, believes this approach could help explore how other organs fare in space. Kim and his team now plan to send more tissues into space for longer periods to deepen their understanding and test potential drugs to counteract microgravity's effects on the heart.